Pub Date : 2026-02-01Epub Date: 2025-10-31DOI: 10.1016/j.jpeds.2025.114880
Rebekah Mannix MD, MPH , Megan Hannon MD , Kara Hennelly MD , Christina Master MD , Daniel Corwin MD, MSCE , Mohamed Badawy MD , Ashley A. Foster MD , Danny Thomas MD, MPH , Laura Blackwell PhD , Andrew Reisner MD , Geoff Manley MD, PhD
Objective
To evaluate the role of blood-based biomarkers in pediatric traumatic brain injury (TBI) using a clinical decision analysis (CDA) framework, with the goal of determining whether biomarker integration improves diagnostic accuracy, reduces unnecessary imaging, and supports clinical decision-making.
Study design
We developed a CDA model to compare standard clinical assessment strategies/decision rules for children with suspected mild TBI vs strategies incorporating biomarker measurement. Model inputs included published estimates of biomarker test performance (sensitivity, specificity), rates of clinically important TBI, and imaging utilization. Outcomes included diagnostic yield, false-positive and false-negative rates, and projected reductions in neuroimaging. Sensitivity analyses explored the robustness of findings across a range of disease prevalences.
Results
Biomarker-enhanced strategies consistently reduced unnecessary head computed tomography utilization compared with clinical assessment alone. Decision-analytic modeling indicated that its integration into assessment strategies could meaningfully decrease radiation exposure at a population level. Sensitivity analyses demonstrated that findings were robust across plausible ranges of injury prevalence.
Conclusions
Application of CDA to pediatric TBI demonstrates the potential value of biomarker integration in improving diagnostic accuracy and optimizing computed tomography utilization. Biomarker-augmented strategies may enhance patient safety by reducing unnecessary radiation exposure, while maintaining sensitivity for clinically important injuries. Prospective validation and real-world implementation studies are needed to confirm clinical effectiveness and cost-effectiveness.
{"title":"Evaluating Diagnostic Strategies for Pediatric Traumatic Brain Injury: A Literature-Based Clinical Decision Analysis","authors":"Rebekah Mannix MD, MPH , Megan Hannon MD , Kara Hennelly MD , Christina Master MD , Daniel Corwin MD, MSCE , Mohamed Badawy MD , Ashley A. Foster MD , Danny Thomas MD, MPH , Laura Blackwell PhD , Andrew Reisner MD , Geoff Manley MD, PhD","doi":"10.1016/j.jpeds.2025.114880","DOIUrl":"10.1016/j.jpeds.2025.114880","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the role of blood-based biomarkers in pediatric traumatic brain injury (TBI) using a clinical decision analysis (CDA) framework, with the goal of determining whether biomarker integration improves diagnostic accuracy, reduces unnecessary imaging, and supports clinical decision-making.</div></div><div><h3>Study design</h3><div>We developed a CDA model to compare standard clinical assessment strategies/decision rules for children with suspected mild TBI vs strategies incorporating biomarker measurement. Model inputs included published estimates of biomarker test performance (sensitivity, specificity), rates of clinically important TBI, and imaging utilization. Outcomes included diagnostic yield, false-positive and false-negative rates, and projected reductions in neuroimaging. Sensitivity analyses explored the robustness of findings across a range of disease prevalences.</div></div><div><h3>Results</h3><div>Biomarker-enhanced strategies consistently reduced unnecessary head computed tomography utilization compared with clinical assessment alone. Decision-analytic modeling indicated that its integration into assessment strategies could meaningfully decrease radiation exposure at a population level. Sensitivity analyses demonstrated that findings were robust across plausible ranges of injury prevalence.</div></div><div><h3>Conclusions</h3><div>Application of CDA to pediatric TBI demonstrates the potential value of biomarker integration in improving diagnostic accuracy and optimizing computed tomography utilization. Biomarker-augmented strategies may enhance patient safety by reducing unnecessary radiation exposure, while maintaining sensitivity for clinically important injuries. Prospective validation and real-world implementation studies are needed to confirm clinical effectiveness and cost-effectiveness.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"289 ","pages":"Article 114880"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145433018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-21DOI: 10.1016/j.jpeds.2025.114927
Aisha Jameel MD, Troy Richardson PhD, Jonathan L. Slaughter MD, MPH
{"title":"Kernicterus Case Incidence Unchanged Since the 2022 American Academy of Pediatrics Hyperbilirubinemia Guideline Revision","authors":"Aisha Jameel MD, Troy Richardson PhD, Jonathan L. Slaughter MD, MPH","doi":"10.1016/j.jpeds.2025.114927","DOIUrl":"10.1016/j.jpeds.2025.114927","url":null,"abstract":"","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"289 ","pages":"Article 114927"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145589539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-06DOI: 10.1016/j.jpeds.2025.114894
Hai Wang MD
{"title":"Shifts in Pediatric Acute Mastoiditis: Unexplored Drivers and Management Implications","authors":"Hai Wang MD","doi":"10.1016/j.jpeds.2025.114894","DOIUrl":"10.1016/j.jpeds.2025.114894","url":null,"abstract":"","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"289 ","pages":"Article 114894"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-07DOI: 10.1016/j.jpeds.2025.114892
Ángela Milena Díaz Díaz MD, Daniela Hernández Quiñones MD, Paul Anthony Camacho López MD, MSc
{"title":"Entering Subspecialties in Pediatrics: More Than Just a Matter of Mentoring","authors":"Ángela Milena Díaz Díaz MD, Daniela Hernández Quiñones MD, Paul Anthony Camacho López MD, MSc","doi":"10.1016/j.jpeds.2025.114892","DOIUrl":"10.1016/j.jpeds.2025.114892","url":null,"abstract":"","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"289 ","pages":"Article 114892"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-10-17DOI: 10.1016/j.jpeds.2025.114859
Sandra G.S. Beauman MSN, RNC-NIC , Zhuopei Hu MS , Ward Rice MD, PhD , Lori Devlin DO , Stephanie L. Merhar MD , Camille M. Fung MD , Jaime Brown MD , Ahmed Osman MD , Adrienne Pahl MD , Kara Wong Ramsey MD , Bonny Whalen MD , Kathryn Dee L. MacMillan MD, MPH , Song T. Ounpraseuth PhD , Abhik Das PhD , Margaret M. Crawford BS , Lillian Trochinski BSN, RN , Rachel G. Greenberg MD , P. Brian Smith MD , Leslie W. Young MD , Jessie R. Maxwell MD, MBA
Objective
To evaluate associations between care approach (usual care vs Eat, Sleep, Console [ESC]) on infant outcomes, and how these associations were modified by medication (buprenorphine or methadone) for opioid use disorder (MOUD).
Study design
A post hoc, subgroup analysis was conducted on infants with antenatal exposure to MOUD enrolled in Eat, Sleep, Console for Neonatal Opioid Withdrawal (ESC-NOW), a multicenter, stepped-wedge, cluster-randomized controlled trial.
Results
There were 949 infants enrolled in the Eat, Sleep, Console for Neonatal Opioid Withdrawal trial and exposed to MOUD (604 buprenorphine, 345 methadone). Infants managed with ESC vs usual care were less likely to receive pharmacologic treatment for NOWS (57.4% vs 18.0%; absolute difference 39.4%; 95% CI: 30.6-48.2; P < .001). Length of hospital stay was 5.4 days shorter (95% CI: 1.9, 8.8; P = .003) in the ESC group. Stratified by MOUD type, infants exposed to methadone managed with ESC had a 9.5 day (95% CI: 4.8-14.2) shorter length of treatment than those managed with usual care (11.1 vs 20.6 days). No significant difference was found between care approaches in length of treatment for buprenorphine-exposed infants (12.3 vs 13.1 days; 95% CI: −4.4 to 6.1).
Conclusions
Use of the ESC care approach was associated with a decrease in pharmacologic treatment for NOWS and a shorter hospital stay for infants with antenatal MOUD exposure. Methadone exposure was associated with a shorter length of pharmacologic treatment for infants cared for with ESC when compared with usual care, whereas such an association was not seen for buprenorphine exposed infants.
Trial registration
https://clinicaltrials.gov/study/NCT04057820.
目的:评价护理方法(常规护理与饮食、睡眠、安慰)对婴儿结局的影响,以及阿片类药物使用障碍(mod)的药物治疗(丁丙诺啡或美沙酮)如何改变这些影响。研究设计:对参加进食、睡眠、安慰治疗新生儿阿片类药物戒断(ESC-NOW)的产前暴露于mod的婴儿进行了一项事后亚组分析,这是一项多中心、楔步式、聚类随机对照试验。结果:共有949名婴儿参加了ESC-NOW试验,并暴露于mod(604名丁丙诺啡,345名美沙酮)。与常规护理相比,ESC治疗的婴儿接受NOWS药物治疗的可能性更小(57.4% vs 18.0%;绝对差值39.4%;95% CI: 30.6-48.2; P < 0.001)。ESC组的住院时间缩短了5.4天(95% CI: 1.9, 8.8; P = 0.003)。按mod类型分层,接受ESC治疗的美沙酮暴露婴儿的治疗时间(LOT)比接受常规治疗的婴儿短9.5天(95% CI: 4.8-14.2)(11.1天vs 20.6天)。丁丙诺啡暴露婴儿的LOT护理方法之间无显著差异(12.3天vs 13.1天;95% CI: -4.4-6.1)。结论:使用ESC护理方法与NOWS的药物治疗减少和产前暴露于mod的婴儿住院时间缩短有关。与常规护理相比,接受ESC护理的婴儿美沙酮暴露与更短的药物治疗时间相关,而丁丙诺啡暴露的婴儿则没有这种关联。
{"title":"Antenatal Exposure to Medication for Opioid Use Disorder and Infant Outcomes in the Eat, Sleep, Console for Neonatal Opioid Withdrawal Randomized Controlled Trial","authors":"Sandra G.S. Beauman MSN, RNC-NIC , Zhuopei Hu MS , Ward Rice MD, PhD , Lori Devlin DO , Stephanie L. Merhar MD , Camille M. Fung MD , Jaime Brown MD , Ahmed Osman MD , Adrienne Pahl MD , Kara Wong Ramsey MD , Bonny Whalen MD , Kathryn Dee L. MacMillan MD, MPH , Song T. Ounpraseuth PhD , Abhik Das PhD , Margaret M. Crawford BS , Lillian Trochinski BSN, RN , Rachel G. Greenberg MD , P. Brian Smith MD , Leslie W. Young MD , Jessie R. Maxwell MD, MBA","doi":"10.1016/j.jpeds.2025.114859","DOIUrl":"10.1016/j.jpeds.2025.114859","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate associations between care approach (usual care vs Eat, Sleep, Console [ESC]) on infant outcomes, and how these associations were modified by medication (buprenorphine or methadone) for opioid use disorder (MOUD).</div></div><div><h3>Study design</h3><div>A <em>post hoc</em>, subgroup analysis was conducted on infants with antenatal exposure to MOUD enrolled in Eat, Sleep, Console for Neonatal Opioid Withdrawal (ESC-NOW), a multicenter, stepped-wedge, cluster-randomized controlled trial.</div></div><div><h3>Results</h3><div>There were 949 infants enrolled in the Eat, Sleep, Console for Neonatal Opioid Withdrawal trial and exposed to MOUD (604 buprenorphine, 345 methadone). Infants managed with ESC vs usual care were less likely to receive pharmacologic treatment for NOWS (57.4% vs 18.0%; absolute difference 39.4%; 95% CI: 30.6-48.2; <em>P</em> < .001). Length of hospital stay was 5.4 days shorter (95% CI: 1.9, 8.8; <em>P</em> = .003) in the ESC group. Stratified by MOUD type, infants exposed to methadone managed with ESC had a 9.5 day (95% CI: 4.8-14.2) shorter length of treatment than those managed with usual care (11.1 vs 20.6 days). No significant difference was found between care approaches in length of treatment for buprenorphine-exposed infants (12.3 vs 13.1 days; 95% CI: −4.4 to 6.1).</div></div><div><h3>Conclusions</h3><div>Use of the ESC care approach was associated with a decrease in pharmacologic treatment for NOWS and a shorter hospital stay for infants with antenatal MOUD exposure. Methadone exposure was associated with a shorter length of pharmacologic treatment for infants cared for with ESC when compared with usual care, whereas such an association was not seen for buprenorphine exposed infants.</div></div><div><h3>Trial registration</h3><div><span><span>https://clinicaltrials.gov/study/NCT04057820</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"289 ","pages":"Article 114859"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-01DOI: 10.1016/j.jpeds.2025.114887
Kayla Covert PT, DPT , Brittany Davis MS , Kendall Hammonds MPH , Taylor Gilliland MS , Nicholas Douville MD , Simon Driver PhD , Morgan O'Neil PhD
Objective
To examine clinic-based health care use (HU) patterns (prolonged use, accessibility continuity, comprehensiveness, and intensity) in children with acute and subacute concussion.
Study design
This retrospective cohort study included patients aged 5-17 years receiving specialty care at an interdisciplinary sports concussion clinic. Patients were dichotomized on the basis of index visit chronicity: acute (≤3 days) and subacute (>3 days) postinjury. Prolonged HU, the primary outcome, was defined as having any follow-up visit >28 days from the index visit. Other measures of HU (accessibility [distance from clinic, insurance status], continuity [visit pacing], comprehensiveness [number and type of referrals], and intensity [number of follow-up visits]) as well as recovery and treatment time were obtained. Multivariable regressions were completed using confounders based upon established literature.
Results
Of 622 patients, 362 (58.2%) presented acutely and 260 (41.8%) subacutely. The acute group was more likely to have a history of motion sickness (P = .02), a sport-related mechanism of injury (P = .006), and migrainous presentation (P = .0005), whereas the subacute group was slightly older (P = .002). Despite differences in presentation timing, no significant differences were observed in prolonged HU (P = .17), distance from clinic (P = .41), or insurance status (P = .36). However, patients in the acute group had significantly lower pacing of visits (ie, continuity; P < .001) with greater number of follow-ups (ie, intensity; P < .001) but were less likely to receive interdisciplinary referrals (P < .001). After adjusting for confounding clinical variables, no significant differences in treatment duration were observed between the two groups (P = .90).
Conclusions
Initiation of concussion care within 1 week of injury demonstrates comparable effectiveness regardless of exact timing, although early presentation favors single-provider management whereas later presentation requires enhanced interdisciplinary coordination.
{"title":"Examining Clinic-Based Health Care Use Patterns in a Specialty Concussion Care Setting","authors":"Kayla Covert PT, DPT , Brittany Davis MS , Kendall Hammonds MPH , Taylor Gilliland MS , Nicholas Douville MD , Simon Driver PhD , Morgan O'Neil PhD","doi":"10.1016/j.jpeds.2025.114887","DOIUrl":"10.1016/j.jpeds.2025.114887","url":null,"abstract":"<div><h3>Objective</h3><div>To examine clinic-based health care use (HU) patterns (prolonged use, accessibility continuity, comprehensiveness, and intensity) in children with acute and subacute concussion.</div></div><div><h3>Study design</h3><div>This retrospective cohort study included patients aged 5-17 years receiving specialty care at an interdisciplinary sports concussion clinic. Patients were dichotomized on the basis of index visit chronicity: acute (≤3 days) and subacute (>3 days) postinjury. Prolonged HU, the primary outcome, was defined as having any follow-up visit >28 days from the index visit. Other measures of HU (accessibility [distance from clinic, insurance status], continuity [visit pacing], comprehensiveness [number and type of referrals], and intensity [number of follow-up visits]) as well as recovery and treatment time were obtained. Multivariable regressions were completed using confounders based upon established literature.</div></div><div><h3>Results</h3><div>Of 622 patients, 362 (58.2%) presented acutely and 260 (41.8%) subacutely. The acute group was more likely to have a history of motion sickness (<em>P</em> = .02), a sport-related mechanism of injury (<em>P</em> = .006), and migrainous presentation (<em>P</em> = .0005), whereas the subacute group was slightly older (<em>P</em> = .002). Despite differences in presentation timing, no significant differences were observed in prolonged HU (<em>P</em> = .17), distance from clinic (<em>P</em> = .41), or insurance status (<em>P</em> = .36). However, patients in the acute group had significantly lower pacing of visits (ie, continuity; <em>P</em> < .001) with greater number of follow-ups (ie, intensity; <em>P</em> < .001) but were less likely to receive interdisciplinary referrals (<em>P</em> < .001). After adjusting for confounding clinical variables, no significant differences in treatment duration were observed between the two groups (<em>P</em> = .90).</div></div><div><h3>Conclusions</h3><div>Initiation of concussion care within 1 week of injury demonstrates comparable effectiveness regardless of exact timing, although early presentation favors single-provider management whereas later presentation requires enhanced interdisciplinary coordination.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"289 ","pages":"Article 114887"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145433039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-11-01DOI: 10.1016/j.jpeds.2025.114883
Luke R. Allen PhD , Cody G. Dodd PhD , Christine N. Moser PsyD , Michelle M. Knoll MD
Objective
To examine changes in suicidality following hormone therapy (HT) among transgender and gender-diverse adolescents and young adults.
Study design
A retrospective chart review was conducted at a multidisciplinary gender health clinic with 432 patients (mean follow-up = 679 days) completing the Ask Suicide-Screening Questions before and after treatment initiation. A repeated-measures ANCOVA assessed within-person changes in suicidality over time, adjusting for age at treatment and treatment duration.
Results
Suicidality significantly declined from pretreatment to post-treatment (F[1, 426] = 34.63, P < .001, partial η2 = 0.075). This effect was consistent across sex assigned at birth, age at start of therapy, and treatment duration.
Conclusions
HT was associated with clinically meaningful reductions in suicidality over time, extending prior findings with a larger sample and longer follow-up. These study findings provide clinical evidence supporting the mental health benefits of timely access to HT in this population.
目的:探讨跨性别和性别多样化的青少年和年轻人在激素治疗(HT)后自杀率的变化。研究设计:在一家多学科性别健康诊所对432名患者(平均随访= 679天)在治疗开始前后完成自杀筛查问题(ASQ)进行回顾性图表回顾。重复测量ANCOVA评估随时间的个人自杀率变化,调整治疗时的年龄和治疗持续时间。结果:治疗前后自杀率显著下降(F[1,426] = 34.63, P < 0.001,偏η2 = 0.075)。这种效应在出生时的性别、治疗开始时的年龄和治疗持续时间中都是一致的。结论:随着时间的推移,HT与临床意义上的自杀率降低有关,通过更大的样本和更长的随访扩展了先前的发现。这些研究结果提供了临床证据,支持在这一人群中及时获得治疗对心理健康有益。
{"title":"Changes in Suicidality among Transgender Adolescents Following Hormone Therapy: An Extended Study","authors":"Luke R. Allen PhD , Cody G. Dodd PhD , Christine N. Moser PsyD , Michelle M. Knoll MD","doi":"10.1016/j.jpeds.2025.114883","DOIUrl":"10.1016/j.jpeds.2025.114883","url":null,"abstract":"<div><h3>Objective</h3><div>To examine changes in suicidality following hormone therapy (HT) among transgender and gender-diverse adolescents and young adults.</div></div><div><h3>Study design</h3><div>A retrospective chart review was conducted at a multidisciplinary gender health clinic with 432 patients (mean follow-up = 679 days) completing the Ask Suicide-Screening Questions before and after treatment initiation. A repeated-measures ANCOVA assessed within-person changes in suicidality over time, adjusting for age at treatment and treatment duration.</div></div><div><h3>Results</h3><div>Suicidality significantly declined from pretreatment to post-treatment (<em>F</em>[1, 426] = 34.63, <em>P</em> < .001, partial η<sup>2</sup> = 0.075). This effect was consistent across sex assigned at birth, age at start of therapy, and treatment duration.</div></div><div><h3>Conclusions</h3><div>HT was associated with clinically meaningful reductions in suicidality over time, extending prior findings with a larger sample and longer follow-up. These study findings provide clinical evidence supporting the mental health benefits of timely access to HT in this population.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"289 ","pages":"Article 114883"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145433101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-10-24DOI: 10.1016/j.jpeds.2025.114870
C. Blair Burnette PhD , Luke Muentner PhD, MSW
Objective
To examine whether parental incarceration is related to increased risk for disordered eating (ie, fasting, binge eating, purging, and compulsive exercise) among children and adolescents in the US.
Study design
We used data from the 2022 and 2023 National Survey of Children's Health, an annual cross-sectional, nationally representative survey of US children. Analyses were restricted to youth ages 6-17 with parental incarceration data (n = 65 321). Logistic regression models were conducted, adjusting for age, sex, race, ethnicity, parental education, and body mass index.
Results
Both food insecurity and parental incarceration were associated with increased risk of fasting, binge eating, and purging. Youth who experienced parental incarceration had 1.74 greater odds of reporting any disordered eating over the last year. Food insecurity was not a significant moderator in any model. The association between parental incarceration and disordered eating differed across levels of household adverse childhood experience exposure; parental incarceration was related to greater odds of disordered eating only at low household adverse childhood experience exposure and attenuated at higher exposure.
Conclusions
Results suggest that experiencing the incarceration of a parent heightens disordered eating risk independent of FI. However, it is unclear whether parental incarceration exerts unique effects among children with high trauma exposure, which should be explored in future research.
{"title":"Links among Parental Incarceration, Food Insecurity, Household Adverse Childhood Experiences, and Disordered Eating in United States Youth","authors":"C. Blair Burnette PhD , Luke Muentner PhD, MSW","doi":"10.1016/j.jpeds.2025.114870","DOIUrl":"10.1016/j.jpeds.2025.114870","url":null,"abstract":"<div><h3>Objective</h3><div>To examine whether parental incarceration is related to increased risk for disordered eating (ie, fasting, binge eating, purging, and compulsive exercise) among children and adolescents in the US.</div></div><div><h3>Study design</h3><div>We used data from the 2022 and 2023 National Survey of Children's Health, an annual cross-sectional, nationally representative survey of US children. Analyses were restricted to youth ages 6-17 with parental incarceration data (n = 65 321). Logistic regression models were conducted, adjusting for age, sex, race, ethnicity, parental education, and body mass index.</div></div><div><h3>Results</h3><div>Both food insecurity and parental incarceration were associated with increased risk of fasting, binge eating, and purging. Youth who experienced parental incarceration had 1.74 greater odds of reporting any disordered eating over the last year. Food insecurity was not a significant moderator in any model. The association between parental incarceration and disordered eating differed across levels of household adverse childhood experience exposure; parental incarceration was related to greater odds of disordered eating only at low household adverse childhood experience exposure and attenuated at higher exposure.</div></div><div><h3>Conclusions</h3><div>Results suggest that experiencing the incarceration of a parent heightens disordered eating risk independent of FI. However, it is unclear whether parental incarceration exerts unique effects among children with high trauma exposure, which should be explored in future research.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"289 ","pages":"Article 114870"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145370563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-10-23DOI: 10.1016/j.jpeds.2025.114872
Jill S. Halterman MD, MPH , Maria Fagnano MPH, MS , Paul J. Tremblay RN, BSN/ME, AE-C , Tamara T. Perry MD , Hongyue Wang PhD , S. Shahzad Mustafa MD , Allison Ramsey MD , Jessica Stern MD, MS
Objective
To evaluate a school-based intervention for children with moderate-severe persistent/poorly controlled asthma, adding telemedicine consultations with specialists to school-based directly observed therapy of preventive asthma medications in order to optimize management.
Study design
From 2018 to 2024 children aged 4-12 years with moderate-severe/poorly controlled asthma were randomized to Telemedicine Enhanced Asthma Management–Uniting Providers (TEAM-UP) or enhanced usual care. TEAM-UP included daily school-based directly observed therapy and telemedicine visits with asthma specialists. The primary outcome was mean symptom-free days/2 weeks. Analyses used linear mixed and generalized estimating equation models.
Results
We enrolled 326 children (62% participation; mean age 8.4 years; 60% male; 58% Black; 35% Hispanic; 80% Medicaid). The majority (84%) of TEAM-UP participants had ≥1 specialist visit and 74% received school-based DOT (excluding the pandemic). We found that children in TEAM-UP vs enhanced usual care had more symptom-free days (mean difference: 1.32; 95% CI 0.58-2.05) and were less likely to miss school (odds ratio: 0.70; 95% CI 0.52-0.96) or require emergency department visits or hospitalizations for asthma (odds ratio: 0.54; 95% CI 0.31-0.96).
Conclusions
TEAM-UP significantly improved asthma symptoms and reduced health care use, offering a promising model for asthma care in underserved communities.
目的:探讨在学校为基础的哮喘预防药物直接观察治疗(DOT)的基础上,增加专家远程医疗咨询,以优化管理,对中重度持续性/控制不良哮喘儿童进行校本干预。研究设计:从2018年到2024年,4-12岁的中重度/控制不良哮喘儿童被随机分为小组治疗组或强化常规治疗组(eUC)。团队合作包括每天以学校为基础的DOT和哮喘专家的远程医疗访问。主要终点为平均无症状天数/2周(SFDs)。分析采用线性混合和广义估计方程模型。结果:我们招募了326名儿童(62%参与,平均年龄8.4岁,60%男性,58%黑人,35%西班牙裔,80%医疗补助)。大多数(84%)团队参与者进行了≥1次专家访问,74%接受了以学校为基础的DOT(不包括大流行)。我们发现,与eUC相比,团队组的儿童有更多的SFDs(平均差异:1.32;95% CI 0.58-2.05),缺课的可能性更小(OR: 0.70; 95% CI 0.52-0.96),或需要急诊或因哮喘住院的可能性更小(OR: 0.54; 95% CI 0.31-0.96)。结论:团队合作显著改善了哮喘症状,减少了医疗保健使用,为服务不足社区的哮喘护理提供了一种有希望的模式。
{"title":"Effect of the Telemedicine Enhanced Asthma Management–Uniting Providers (TEAM-UP) Program on Asthma Outcomes: A Randomized Clinical Trial","authors":"Jill S. Halterman MD, MPH , Maria Fagnano MPH, MS , Paul J. Tremblay RN, BSN/ME, AE-C , Tamara T. Perry MD , Hongyue Wang PhD , S. Shahzad Mustafa MD , Allison Ramsey MD , Jessica Stern MD, MS","doi":"10.1016/j.jpeds.2025.114872","DOIUrl":"10.1016/j.jpeds.2025.114872","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate a school-based intervention for children with moderate-severe persistent/poorly controlled asthma, adding telemedicine consultations with specialists to school-based directly observed therapy of preventive asthma medications in order to optimize management.</div></div><div><h3>Study design</h3><div>From 2018 to 2024 children aged 4-12 years with moderate-severe/poorly controlled asthma were randomized to Telemedicine Enhanced Asthma Management–Uniting Providers (TEAM-UP) or enhanced usual care. TEAM-UP included daily school-based directly observed therapy and telemedicine visits with asthma specialists. The primary outcome was mean symptom-free days/2 weeks. Analyses used linear mixed and generalized estimating equation models.</div></div><div><h3>Results</h3><div>We enrolled 326 children (62% participation; mean age 8.4 years; 60% male; 58% Black; 35% Hispanic; 80% Medicaid). The majority (84%) of TEAM-UP participants had ≥1 specialist visit and 74% received school-based DOT (excluding the pandemic). We found that children in TEAM-UP vs enhanced usual care had more symptom-free days (mean difference: 1.32; 95% CI 0.58-2.05) and were less likely to miss school (odds ratio: 0.70; 95% CI 0.52-0.96) or require emergency department visits or hospitalizations for asthma (odds ratio: 0.54; 95% CI 0.31-0.96).</div></div><div><h3>Conclusions</h3><div>TEAM-UP significantly improved asthma symptoms and reduced health care use, offering a promising model for asthma care in underserved communities.</div></div><div><h3>Trial registration</h3><div>ClinicalTrials.gov number: NCT03545906 <span><span>https://clinicaltrials.gov/study/NCT03545906?term=NCT03545906&rank=1</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"289 ","pages":"Article 114872"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145370596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}